Last reviewed · How we verify
Conventional group
At a glance
| Generic name | Conventional group |
|---|---|
| Also known as | (NaOCl/EDTA) |
| Sponsor | Future University in Egypt |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS (NA)
- Conventional vs Pulsed RF in Coccydynia (NA)
- Early Surgical Intervention of Congenital Hemivertebra in Young Children (NA)
- Effects of Training With a Pressure Cuff on Cellular Energy Activity (NA)
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer (PHASE3)
- Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart Failure (NYHA Class III-IV) (PHASE3)
- Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Conventional group CI brief — competitive landscape report
- Conventional group updates RSS · CI watch RSS
- Future University in Egypt portfolio CI